A Monod-Wyman-Changeux Mechanism Can Explain G Protein-coupled Receptor (GPCR) Allosteric Modulation
Open Access
- 1 January 2012
- journal article
- research article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 287 (1) , 650-659
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Therapeutic potential of β-arrestin- and G protein-biased agonistsTrends in Molecular Medicine, 2011
- Identification of Orthosteric and Allosteric Site Mutations in M2 Muscarinic Acetylcholine Receptors That Contribute to Ligand-selective Signaling BiasJournal of Biological Chemistry, 2010
- Molecular Mechanisms of Action and In Vivo Validation of an M4 Muscarinic Acetylcholine Receptor Allosteric Modulator with Potential Antipsychotic PropertiesNeuropsychopharmacology, 2009
- A Selective Allosteric Potentiator of the M1Muscarinic Acetylcholine Receptor Increases Activity of Medial Prefrontal Cortical Neurons and Restores Impairments in Reversal LearningJournal of Neuroscience, 2009
- Selective activation of the M 1 muscarinic acetylcholine receptor achieved by allosteric potentiationProceedings of the National Academy of Sciences, 2009
- Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disordersNature Reviews Drug Discovery, 2009
- Negative feedback that improves information transmission in yeast signallingNature, 2008
- A unique mechanism of β-blocker action: Carvedilol stimulates β-arrestin signalingProceedings of the National Academy of Sciences, 2007
- Evolving the lock to fit the key to create a family of G protein-coupled receptors potently activated by an inert ligandProceedings of the National Academy of Sciences, 2007
- On the nature of allosteric transitions: A plausible modelJournal of Molecular Biology, 1965